Regulation

GHO and CBC Merge to Create $21 Billion Healthcare Superpower
Business GHO and CBC Merge to Create $21 Billion Healthcare Superpower

The landscape of international healthcare finance is undergoing a seismic shift as GHO Capital and CBC Group finalize a definitive merger agreement that creates an unrivaled investment powerhouse. This strategic consolidation, announced in the middle of 2026, unites a specialist European healthcare

How Will Delaware’s Senate Bill 1 Reform Healthcare Costs?
Care How Will Delaware’s Senate Bill 1 Reform Healthcare Costs?

Delaware is currently grappling with a significant fiscal challenge as its healthcare expenditures have climbed to become some of the highest in the nation, threatening the economic stability of both families and state budgets. To combat this rising tide of expenses, the state legislature has

FDA Grants Orphan Drug Status to Cullinan AML Therapy
Public Policy FDA Grants Orphan Drug Status to Cullinan AML Therapy

The landscape of hematological oncology is witnessing a significant shift as specialized immunotherapies begin to address the most resilient forms of blood cancer. Acute myeloid leukemia remains a formidable challenge for clinicians, particularly when patients experience a relapse or prove

Are Australian Cannabis Clinics Putting Profit Over Care?
Care Are Australian Cannabis Clinics Putting Profit Over Care?

The rapid expansion of the Australian medicinal cannabis industry since the mid-2010s has transformed the nation’s healthcare landscape, shifting from niche pharmaceutical access to a multi-billion dollar digital enterprise that prioritizes convenience. While the rise of telehealth has s

Is Oregon's Healthcare Merger Law Failing Its Patients?
Care Is Oregon's Healthcare Merger Law Failing Its Patients?

The legislative landscape of the Pacific Northwest was transformed five years ago when Oregon pioneered a regulatory framework designed to halt the aggressive consolidation of medical practices by corporate entities. When the Health Care Market Oversight program was established in 2021, proponents

SERB Acquires European Rights to Hansa’s Kidney Transplant Drug
Care SERB Acquires European Rights to Hansa’s Kidney Transplant Drug

The struggle to find a matching donor for kidney transplantation becomes an almost insurmountable challenge for highly sensitized patients whose immune systems are primed to reject nearly any foreign tissue. This biological barrier has historically relegated thousands of individuals to long-term

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later